Observational studyTargeted oncology2023

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.

Ping-Chih Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.